Serum miR-15a-5p may predict recurrence of atrial fibrillation after catheter ablation: a single center retrospective study

Background There is still a lack of an easily obtainable, sensitive, and specific biomarker for predicting the recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation (RFCA). In the present study, we aimed to investigate the predictive value of serum miR-15a-5p as a biomarker o...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhong-Bao Ruan, Qian Peng, Xiang-Jiang Sun, Fei Wang, Li Zhu
Format: Article
Language:English
Published: PeerJ Inc. 2025-07-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/19618.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850091572501151744
author Zhong-Bao Ruan
Qian Peng
Xiang-Jiang Sun
Fei Wang
Li Zhu
author_facet Zhong-Bao Ruan
Qian Peng
Xiang-Jiang Sun
Fei Wang
Li Zhu
author_sort Zhong-Bao Ruan
collection DOAJ
description Background There is still a lack of an easily obtainable, sensitive, and specific biomarker for predicting the recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation (RFCA). In the present study, we aimed to investigate the predictive value of serum miR-15a-5p as a biomarker of recurrence in AF patients undergoing RFCA. Methods Forty-three consecutive AF patients indicated for RFCA and 20 non-AF subjects were enrolled. The levels of serum miR-15a-5p and PICP, PIIINP, MMP-9, and sST2 were detected. Then, linear regression analysis, binary logistic regression analysis, and receiver operating characteristic (ROC) analysis were used to investigate the correlation between the expression level of serum miR-15a-5p and the degree of myocardial fibrosis and assess the value of serum miR-15a-5p for predicting postoperative recurrence of AF. Results There was a significant difference in age, CK-MB, uric acid (UA), left atrial diameter (LAD), history of coronary heart disease (CAD), and left ventricular ejection fraction (LVEF) between the AF group and the control group (p < 0.05). Compared with the control group, the level of serum miR-15a-5p, MMP-9, PICP, PIIINP, and sST2 was higher in the AF group (p < 0.05 or p < 0.01). miR-15a-5p had a significant and positive relationship with the level of the four serum fibrosis biomarkers (p < 0.05). Compared with paroxysmal AF, persistent AF had a higher increase in serum miR-15a-5p expression level (p < 0.001). Compared with the non-recurrent, the expression level of serum miR-15a-5p in the recurrent patients was significantly increased (p < 0.01). ROC analysis showed that the AUC of serum miR-15a-5p for predicting AF recurrence was 0.823 (95% CI [0.668–0.979], p < 0.01), and the cutoff value was 1.5224, with a sensitivity of 71.4% and specificity of 86.1%. Conclusions The high expression of serum miR-15a-5p in AF patients was related to the degree of myocardial fibrosis and the recurrence of AF after RFCA, which indicated that serum miR-15a-5p could be used as a serum biomarker for predicting AF recurrence after RFCA.
format Article
id doaj-art-56d509182b6f4e50a208c3fdf70190a7
institution DOAJ
issn 2167-8359
language English
publishDate 2025-07-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj-art-56d509182b6f4e50a208c3fdf70190a72025-08-20T02:42:22ZengPeerJ Inc.PeerJ2167-83592025-07-0113e1961810.7717/peerj.19618Serum miR-15a-5p may predict recurrence of atrial fibrillation after catheter ablation: a single center retrospective studyZhong-Bao Ruan0Qian Peng1Xiang-Jiang Sun2Fei Wang3Li Zhu4The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, ChinaCardiology, Nanjing University of Chinese Medicine, Taizhou, ChinaDalian Municipal Central Hospital, Dalian, ChinaThe Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, ChinaThe Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, ChinaBackground There is still a lack of an easily obtainable, sensitive, and specific biomarker for predicting the recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation (RFCA). In the present study, we aimed to investigate the predictive value of serum miR-15a-5p as a biomarker of recurrence in AF patients undergoing RFCA. Methods Forty-three consecutive AF patients indicated for RFCA and 20 non-AF subjects were enrolled. The levels of serum miR-15a-5p and PICP, PIIINP, MMP-9, and sST2 were detected. Then, linear regression analysis, binary logistic regression analysis, and receiver operating characteristic (ROC) analysis were used to investigate the correlation between the expression level of serum miR-15a-5p and the degree of myocardial fibrosis and assess the value of serum miR-15a-5p for predicting postoperative recurrence of AF. Results There was a significant difference in age, CK-MB, uric acid (UA), left atrial diameter (LAD), history of coronary heart disease (CAD), and left ventricular ejection fraction (LVEF) between the AF group and the control group (p < 0.05). Compared with the control group, the level of serum miR-15a-5p, MMP-9, PICP, PIIINP, and sST2 was higher in the AF group (p < 0.05 or p < 0.01). miR-15a-5p had a significant and positive relationship with the level of the four serum fibrosis biomarkers (p < 0.05). Compared with paroxysmal AF, persistent AF had a higher increase in serum miR-15a-5p expression level (p < 0.001). Compared with the non-recurrent, the expression level of serum miR-15a-5p in the recurrent patients was significantly increased (p < 0.01). ROC analysis showed that the AUC of serum miR-15a-5p for predicting AF recurrence was 0.823 (95% CI [0.668–0.979], p < 0.01), and the cutoff value was 1.5224, with a sensitivity of 71.4% and specificity of 86.1%. Conclusions The high expression of serum miR-15a-5p in AF patients was related to the degree of myocardial fibrosis and the recurrence of AF after RFCA, which indicated that serum miR-15a-5p could be used as a serum biomarker for predicting AF recurrence after RFCA.https://peerj.com/articles/19618.pdfAtrial fibrillationMiR-15a-5pRecurrenceRadiofrequency catheter ablationPredict
spellingShingle Zhong-Bao Ruan
Qian Peng
Xiang-Jiang Sun
Fei Wang
Li Zhu
Serum miR-15a-5p may predict recurrence of atrial fibrillation after catheter ablation: a single center retrospective study
PeerJ
Atrial fibrillation
MiR-15a-5p
Recurrence
Radiofrequency catheter ablation
Predict
title Serum miR-15a-5p may predict recurrence of atrial fibrillation after catheter ablation: a single center retrospective study
title_full Serum miR-15a-5p may predict recurrence of atrial fibrillation after catheter ablation: a single center retrospective study
title_fullStr Serum miR-15a-5p may predict recurrence of atrial fibrillation after catheter ablation: a single center retrospective study
title_full_unstemmed Serum miR-15a-5p may predict recurrence of atrial fibrillation after catheter ablation: a single center retrospective study
title_short Serum miR-15a-5p may predict recurrence of atrial fibrillation after catheter ablation: a single center retrospective study
title_sort serum mir 15a 5p may predict recurrence of atrial fibrillation after catheter ablation a single center retrospective study
topic Atrial fibrillation
MiR-15a-5p
Recurrence
Radiofrequency catheter ablation
Predict
url https://peerj.com/articles/19618.pdf
work_keys_str_mv AT zhongbaoruan serummir15a5pmaypredictrecurrenceofatrialfibrillationaftercatheterablationasinglecenterretrospectivestudy
AT qianpeng serummir15a5pmaypredictrecurrenceofatrialfibrillationaftercatheterablationasinglecenterretrospectivestudy
AT xiangjiangsun serummir15a5pmaypredictrecurrenceofatrialfibrillationaftercatheterablationasinglecenterretrospectivestudy
AT feiwang serummir15a5pmaypredictrecurrenceofatrialfibrillationaftercatheterablationasinglecenterretrospectivestudy
AT lizhu serummir15a5pmaypredictrecurrenceofatrialfibrillationaftercatheterablationasinglecenterretrospectivestudy